Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from NDTV News - Special https://ift.tt/3nX8fwP
Subscribe to:
Post Comments (Atom)
OnePlus 13s Is Tailor-Made for India's Compact Phone Needs: OnePlus CEO
OnePlus 13s, the company's first compact smartphone ever, is all set to launch in India soon. Now, OnePlus is a brand that doesn't h...
-
R Krishnakumar, a close aide of Ratan Tata and a group veteran, died Sunday evening, officials said. Kerala-born Krishnakumar, who had serv...
-
Idli is an unarguably all-time favourite of Indians. Period! The steamed, puffy and easy to digest, South Indian dish has an interesting sto...
No comments:
Post a Comment